AAPL   321.67 (+1.17%)
MSFT   182.32 (-0.51%)
FB   229.81 (+2.10%)
GOOGL   1,430.56 (-0.21%)
AMZN   2,467.93 (+1.05%)
NVDA   353.27 (-0.49%)
CGC   16.82 (-3.17%)
BABA   205.66 (-0.83%)
MU   46.60 (-2.73%)
GE   6.68 (+1.67%)
TSLA   883.60 (+5.82%)
AMD   53.57 (-0.43%)
T   31.09 (+0.75%)
ACB   14.40 (+2.27%)
F   5.82 (+1.93%)
NFLX   424.25 (+1.08%)
BAC   24.62 (+2.07%)
BA   151.87 (+4.28%)
AAPL   321.67 (+1.17%)
MSFT   182.32 (-0.51%)
FB   229.81 (+2.10%)
GOOGL   1,430.56 (-0.21%)
AMZN   2,467.93 (+1.05%)
NVDA   353.27 (-0.49%)
CGC   16.82 (-3.17%)
BABA   205.66 (-0.83%)
MU   46.60 (-2.73%)
GE   6.68 (+1.67%)
TSLA   883.60 (+5.82%)
AMD   53.57 (-0.43%)
T   31.09 (+0.75%)
ACB   14.40 (+2.27%)
F   5.82 (+1.93%)
NFLX   424.25 (+1.08%)
BAC   24.62 (+2.07%)
BA   151.87 (+4.28%)
AAPL   321.67 (+1.17%)
MSFT   182.32 (-0.51%)
FB   229.81 (+2.10%)
GOOGL   1,430.56 (-0.21%)
AMZN   2,467.93 (+1.05%)
NVDA   353.27 (-0.49%)
CGC   16.82 (-3.17%)
BABA   205.66 (-0.83%)
MU   46.60 (-2.73%)
GE   6.68 (+1.67%)
TSLA   883.60 (+5.82%)
AMD   53.57 (-0.43%)
T   31.09 (+0.75%)
ACB   14.40 (+2.27%)
F   5.82 (+1.93%)
NFLX   424.25 (+1.08%)
BAC   24.62 (+2.07%)
BA   151.87 (+4.28%)
AAPL   321.67 (+1.17%)
MSFT   182.32 (-0.51%)
FB   229.81 (+2.10%)
GOOGL   1,430.56 (-0.21%)
AMZN   2,467.93 (+1.05%)
NVDA   353.27 (-0.49%)
CGC   16.82 (-3.17%)
BABA   205.66 (-0.83%)
MU   46.60 (-2.73%)
GE   6.68 (+1.67%)
TSLA   883.60 (+5.82%)
AMD   53.57 (-0.43%)
T   31.09 (+0.75%)
ACB   14.40 (+2.27%)
F   5.82 (+1.93%)
NFLX   424.25 (+1.08%)
BAC   24.62 (+2.07%)
BA   151.87 (+4.28%)
Log in

NYSE:XANExantas Capital Stock Price, Forecast & News

$2.17
+0.17 (+8.50 %)
(As of 06/1/2020 02:18 PM ET)
Add
Compare
Today's Range
$2.01
Now: $2.17
$2.23
50-Day Range
$1.98
MA: $2.52
$3.48
52-Week Range
$0.95
Now: $2.17
$12.51
Volume67,511 shs
Average Volume1.35 million shs
Market Capitalization$69.53 million
P/E RatioN/A
Dividend YieldN/A
Beta1.39
Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments related to commercial real estate (CRE), commercial mortgage-backed securities, and CRE equity investments. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. It generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Resource Capital Corp. and changed its name to Exantas Capital Corp. in May 2018. Exantas Capital Corp. was founded in 2005 and is based in New York, New York.
Read More
Exantas Capital logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.10 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
CUSIPN/A
CIKN/A
Phone212-621-3210

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$61.15 million
Cash Flow$1.63 per share
Book Value$17.45 per share

Profitability

Net Income$35.97 million
Net Margins-274.26%

Miscellaneous

EmployeesN/A
Market Cap$69.53 million
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive XAN News and Ratings via Email

Sign-up to receive the latest news and ratings for XAN and its competitors with MarketBeat's FREE daily newsletter.

Exantas Capital (NYSE:XAN) Frequently Asked Questions

How has Exantas Capital's stock been impacted by COVID-19 (Coronavirus)?

Exantas Capital's stock was trading at $9.75 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, XAN shares have decreased by 77.7% and is now trading at $2.17. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Exantas Capital?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exantas Capital in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Exantas Capital.

When is Exantas Capital's next earnings date?

Exantas Capital is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Exantas Capital.

How were Exantas Capital's earnings last quarter?

Exantas Capital Corp (NYSE:XAN) posted its earnings results on Thursday, May, 7th. The company reported $0.23 earnings per share for the quarter, missing the consensus estimate of $0.30 by $0.07. The firm had revenue of $14.90 million for the quarter. Exantas Capital had a positive return on equity of 7.95% and a negative net margin of 274.26%. View Exantas Capital's earnings history.

How often does Exantas Capital pay dividends? What is the dividend yield for Exantas Capital?

Exantas Capital declared a quarterly dividend on Friday, March 13th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.275 per share on Tuesday, April 28th. This represents a $1.10 dividend on an annualized basis and a yield of 50.69%. The ex-dividend date of this dividend is Monday, March 30th. View Exantas Capital's dividend history.

What price target have analysts set for XAN?

2 analysts have issued 1-year target prices for Exantas Capital's shares. Their forecasts range from $4.00 to $4.00. On average, they expect Exantas Capital's share price to reach $4.00 in the next year. This suggests a possible upside of 84.3% from the stock's current price. View analysts' price targets for Exantas Capital.

Has Exantas Capital been receiving favorable news coverage?

Media stories about XAN stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Exantas Capital earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutExantas Capital.

Are investors shorting Exantas Capital?

Exantas Capital saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 2,690,000 shares, an increase of 111.8% from the April 30th total of 1,270,000 shares. Based on an average daily trading volume, of 1,410,000 shares, the days-to-cover ratio is currently 1.9 days. Approximately 8.7% of the company's shares are sold short. View Exantas Capital's Current Options Chain.

Who are some of Exantas Capital's key competitors?

What other stocks do shareholders of Exantas Capital own?

Who are Exantas Capital's key executives?

Exantas Capital's management team includes the following people:
  • Mr. Robert C. Lieber, Chief Exec. Officer (Age 65)
  • Mr. Matthew J. Stern, Pres (Age 45)
  • Mr. David J. Bryant, Sr. VP, CFO & Treasurer (Age 61)
  • Mr. Thomas C. Elliott, Exec. VP of Fin. & Operations (Age 46)
  • Mr. Eldron C. Blackwell, VP & Chief Accounting Officer (Age 40)

What is Exantas Capital's stock symbol?

Exantas Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "XAN."

Who are Exantas Capital's major shareholders?

Exantas Capital's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.83%), HBK Investments L P (4.89%), State Street Corp (3.68%), Wolverine Asset Management LLC (2.12%), Bayview Asset Management LLC (1.97%) and Acadian Asset Management LLC (1.11%). Company insiders that own Exantas Capital stock include David J Bryant, Robert C Lieber, Stephanie H Wiggins and Thomas C Elliott. View institutional ownership trends for Exantas Capital.

Which institutional investors are selling Exantas Capital stock?

XAN stock was sold by a variety of institutional investors in the last quarter, including HBK Investments L P, Bayview Asset Management LLC, Parametric Portfolio Associates LLC, Martingale Asset Management L P, Morgan Stanley, BlackRock Inc., Wells Fargo & Company MN, and Mackenzie Financial Corp. View insider buying and selling activity for Exantas Capital.

Which institutional investors are buying Exantas Capital stock?

XAN stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, Wolverine Asset Management LLC, Advisor Group Holdings Inc., WINTON GROUP Ltd, Two Sigma Advisers LP, Los Angeles Capital Management & Equity Research Inc., Aigen Investment Management LP, and Mackay Shields LLC. Company insiders that have bought Exantas Capital stock in the last two years include David J Bryant, Robert C Lieber, and Thomas C Elliott. View insider buying and selling activity for Exantas Capital.

How do I buy shares of Exantas Capital?

Shares of XAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Exantas Capital's stock price today?

One share of XAN stock can currently be purchased for approximately $2.17.

How big of a company is Exantas Capital?

Exantas Capital has a market capitalization of $69.53 million and generates $61.15 million in revenue each year. The company earns $35.97 million in net income (profit) each year or $1.00 on an earnings per share basis.

What is Exantas Capital's official website?

The official website for Exantas Capital is www.exantas.com.

How can I contact Exantas Capital?

Exantas Capital's mailing address is 717 FIFTH AVENUE, NEW YORK NY, 10022. The company can be reached via phone at 212-621-3210 or via email at [email protected]

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.